Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
- Bella Kaufman*
- , Steven Stein
- , Michelle A. Casey
- , Beth O. Newstat
*Corresponding author for this work
- GlaxoSmithKline
Research output: Contribution to journal › Review article › peer-review
16
Scopus
citations